gene therapy muscular dystrophy - Search News

Order byBest matchMost fresh

News

FDA, Sarepta and gene therapy

· 1d · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

Continue reading

Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

MedPage Today · 2d

Drugmaker Refuses FDA's Request to Pull Gene Therapy Tied to Patient Deaths

2don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Fierce Biotech2d

Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy

The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb-girdle ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results